Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;335:1066-1067 (24 November), doi:10.1136/bmj.39405.462431.94
Nicholas Timmins, public policy editor, Financial Times
Nicholas Timmins considers whether the government's decision to cut back its planned use of the private sector in the NHS is pragmatic or ideological
| The first 150 words of the full text of this article appear below. |
Happy trade unions, a fuming private sector, bewildered taxpayers, patients who are still waiting, and—almost certainly—an inquiry by the National Audit Office.
That was the outcome of health secretary Alan Johnson's announcement last week that only three more schemes are definitely going ahead from the second wave of contracts for diagnostic services and new independent sector treatment centres in England.
Mr Johnson's written statement dealt merely with the 16 contracts still extant from a negotiation that has been going on for three years now. Six other schemes were cancelled. Seven remain under procurement—although the health department says that there is "no guarantee" they will go ahead, despite giving private assurances to the companies that they will.
But behind Mr Johnson's studiedly low key statement was a bigger picture. What, under Tony Blair's government, was originally meant to be about £6bn (
8.4bn; $12.3bn) worth of business for the private sector
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses